Expression of an E1A/E7 Chimeric Protein Sensitizes Tumor Cells to Killing by Activated Macrophages but Not NK Cells

Journal of Virology

Volumn 78, Issue 9, 2004, Pages 4646-4654

  Miura, Tanya A ^a   Li, Han ^a   Morris, Kristin ^a   Ryan, Sharon ^a   Hembre, Kristine ^a   Cook, James L ^b   Routes, John M ^a,c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CHIMERIC PROTEIN; E1A PROTEIN; ONCOPROTEIN; PROTEIN E7; PROTEIN P300;

ADENOVIRUS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CARCINOGENICITY; CHIMERA; FIBROSARCOMA; GENE MAPPING; GENETIC DIFFERENCE; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SENSITIZATION; TUMOR CELL; VIRUS STRAIN; WART VIRUS;

ADENOVIRUS E1A PROTEINS; ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RATS; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

EID: 10644248516     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.9.4646-4654.2004     Document Type: Article

References (58)

1. Banks, L., F. Moreau, K. Vousden, D. Pim, and G. Matlashewski. 1991. Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages. J. Immunol. 146:2037-2042.
2. Bernards, R., A. Houweling, P. I. Schrier, J. L. Bos, and A. J. van der Eb. 1982. Characterization of cells transformed by Ad5/Ad12 hybrid early region I plasmids. Virology 120:422-432.
3. Bernat, A., N. Awakumov, J. S. Mymryk, and L. Banks. 2003. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300. Oncogene 22:5927-5937.
4. Bordoli, L., S. Husser, U. Luthi, M. Netsch, H. Osmani, and R. Eckner. 2001. Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity. Nucleic Acids Res. 29:4462-4471.
5. Bosch, F. X., M. M. Manos, N. Muñoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
6. Brokaw, J. L., C. L. Yee, and K. Munger. 1994. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein. Virology 205:603-607.
7. Chakravarti, D., V. Ogryzko, H. Y. Kao, A. Nash, H. Chen, Y. Nakatani, and R. M. Evans. 1999. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96:393-403.
8. Chinnadurai, G. 2002. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol. Cell 9:213-224.
9. Cook, J. L., C. K. Krantz, and B. A. Routes. 1996. Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection. Proc. Natl. Acad. Sci. USA 93:13985-13990.
10. Cook, J. L., D. L. May, A. Lewis, Jr., and T. A. Walker. 1987. Adenovirus E1A gene induction of susceptibility to lysis by natural killer cells and activated macrophages in infected rodent cells. J. Virol. 61:3510-3520.
11. Cook, J. L., D. L. May, B. A. Wilson, B. Holskin, M. J. Chen, D. Shalloway, and T. A. Walker. 1989. Role of tumor necrosis factor-alpha in E1A oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages. J. Immunol. 142:4527-4534.
12. Cook, J. L., D. L. May, B. A. Wilson, and T. A. Walker. 1989. Differential induction of cytolytic susceptibility by E1A, myc, and ras oncogenes in immortalized cells. J. Virol. 63:3408-3415.
13. Cook, J. L., T. A. Miura, D. N. Ikle, J. A. M. Lewis, and J. M. Routes. 2003. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo. Cancer Res. 63:3435-3443.
14. Cook, J. L., T. A. Potter, D. Bellgrau, and B. A. Routes. 1996. E1A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes. Oncogene 13:833-842.
15. Cook, J. L., B. A. Routes, T. A. Walker, K. L. Colvin, and J. M. Routes. 1999. E1A oncogene induction of cellular susceptibility to killing by cytolytic lymphocytes through target cell sensitization to apoptotic injury. Exp. Cell Res. 251:414-423.
16. Cook, J. L., T. A. Walker, A. M. Lewis, Jr., H. E. Ruley, F. L. Graham, and S. H. Pilder. 1986. Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells. Proc. Natl. Acad. Sci. USA 83:6965-6969.
17. Cook, J. L., T. A. Walker, G. S. Worthen, and J. R. Radke. 2002. Role of the E1A Rb-binding domain in repression of the NF-kB-dependent defense against tumor necrosis factor-alpha. Proc. Natl. Acad. Sci. USA 99:9966-9971.
18. Cook, J. L., B. A. Wilson, L. A. Wolf, and T. A. Walker. 1993. E1A oncogene expression level in sarcoma cells: an independent determinant of cytolytic susceptibility and tumor rejection. Oncogene 8:625-635.
19. Day, D. B., N. A. Zachariades, and L. R. Gooding. 1994. Cytolysis of adenovirus-infected murine fibroblasts by IFN-γ-primed macrophages is TNF- and contact-dependent. Cell. Immunol. 157:223-238.
20. Dyson, N., P. Guida, K. Munger, and E. Harlow. 1992. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol. 66:6893-6902.
21. Eckner, R., J. Ludlow, N. Lill, E. Oldread, Z. Arany, N. Modjtahedi, J. DeCaprio, D. Livingston, and J. Morgan. 1996. Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 16:3454-3464.
22. Frisch, S. 1991. Antioncogenic effect of adenovirus E1A in human tumor cells. Proc. Natl. Acad. Sci. USA 88:9077-9081.
23. Goodman, R. H., and S. Smolik. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553-1577.
24. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
25. Green, M., W. Wold, J. Mackey, and P. Rigden. 1979. Analysis of human tonsil and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1, 2, 5 and 6) human adenovirus. Proc. Natl. Acad. Sci. USA 76:6606-6610.
26. Harlow, E., R. Franza, Jr., and C. Schley. 1985. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J. Virol. 55:533-546.
27. Helt, A.-M., and D. A. Galloway. 2003. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24:159-169.
28. Howe, J. A., J. S. Mymryk, C. Egan, P. E. Branton, and S. T. Bayley. 1990. Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis. Proc. Natl. Acad. Sci. USA 87:5883-5887.
29. Jayachandra, S., K. G. Low, A.-E. Thlick, J. Yu, P. D. Ling, Y. Chang, and P. S. Moore. 1999. Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc. Natl. Acad. Sci. USA 96:11566-11571.
30. Jelsma, T. N., J. A. Howe, C. M. Evelegh, N. F. Cunniff, M. H. Skiadopoulos, M. R. Floroff, J. E. Denman, and S. T. Bayley. 1988. Use of deletion and point mutants spanning the coding region of the adenovirus 5 E1A gene to define a domain that is essential for transcriptional activation. Virology 163:494-502.
31. Kawasaki, H., R. Eckner, T. P. Yao, K. Taira, R. Chiu, D. M. Livingston, and K. K. Yokoyama. 1998. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 393:284-289.
32. Klefstrom, J., P. E. Kovanen, K. Somersalo, A. O. Hueber, T. Littlewood, G. I. Evan, A. H. Greenberg, E. Saksela, T. Timonen, and K. Alitalo. 1999. c-Myc and E1A induced cellular sensitivity to activated NK cells involves cytotoxic granules as death effectors. Oncogene 18:2181-2188.
33. Krantz, C. K., B. A. Routes, M. P. Quinlan, and J. L. Cook. 1996. E1A second exon requirements for induction of target cell susceptibility to lysis by natural killer cells: implications for the mechanism of action. Virology 217:23-32.
34. Kurokawa, R., D. Kalafus, M.-H. Ogliastro, C. Kioussi, L. Xu, J. Torchia, M. G. Rosenfeld, and C. K. Glass. 1998. Differential use of CREB binding protein-coactivator complexes. Science 279:700-703.
35. Miller, A. D., D. G. Miller, J. V. Garcia, and C. M. Lynch. 1993. Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 217:581.
36. Miura, T. A., K. Morris, S. Ryan, J. L. Cook, and J. M. Routes. 2003. Adenovirus E1A, not human papillomavirus E7, sensitizes tumor cells to lysis by macrophages through nitric oxide- and TNF-a-dependent mechanisms despite up-regulation of 70-kDa heat shock protein. J. Immunol. 170:4119-4126.
37. Munger, K., J. R. Basile, S. Duensing, A. Eichten, S. L. Gonzalez, M. Grace, and V. L. Zacny. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888-7898.
38. Phelps, W. C., S. Bagchi, J. A. Barnes, P. Raychaudhuri, V. Kraus, K. Münger, P. M. Howley, and J. R. Nevins. 1991. Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. J. Virol. 65:6922-6930.
39. Phelps, W. C., C. L. Yee, K. Munger, and P. M. Howley. 1989. Functional and sequence similarities between HPV16 E7 and adenovirus E1A. Curr. Top. Microbiol. Immunol. 144:153-166.
40. Phelps, W. C., C. L. Yee, K. Munger, and P. M. Howley. 1988. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53:539-547.
41. Raska, K., Jr., and P. H. Gallimore. 1982. An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells. Virology 123:8-18.
42. Reis, L. F., H. Harada, J. D. Wolchok, T. Taniguchi, and J. Vilcek. 1992. Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO J. 11:185-193.
43. Reynolds, C., E. Bere, Jr., and J. Ward. 1984. Natural killer activity in the rat. III. Characterization of transplantable large granular lymphocyte (LGL) leukemias in the F344 rat. J. Immunol. 132:534-540.
44. Robertson, M. J., K. J. Cochran, C. Cameron, J. M. Le, R. Tantravahi, and J. Ritz. 1996. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24:406-415.
45. Roth, J. F., N. Shikama, C. Henzen, I. Desbaillets, W. Lutz, S. Marino, J. Wittwer, H. Schorle, M. Gassmann, and R. Eckner. 2003. Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5. EMBO J. 22:5186-5196.
46. Routes, J., S. Ryan, A. Clase, T. Miura, A. Kuhl, T. Potter, and J. Cook. 2000. Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL). J. Immunol. 165:4522-4527.
47. Routes, J., S. Ryan, H. Li, J. Steinke, and J. Cook. 2000. Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development. Virology 277:48-57.
48. Routes, J. M., and J. L. Cook. 1995. E1A gene expression induces susceptibility to killing by NK cells following immortalization but not adenovirus infection of human cells. Virology 210:421-428.
49. Routes, J. M., and S. Ryan. 1995. Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells. J. Virol. 69:7639-7647.
50. Sawada, Y., B. Fohring, T. E. Shenk, and K. Raska, Jr. 1985. Tumorigenicity of adenovirus-transformed cells; region E1A of adenovirus 12 confers resistance to natural killer cells. Virology 147:413-421.
51. Vo, N., and R. H. Goodman. 2001. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276:13505-13508.
52. Vousden, K. H., and P. S. Jat. 1989. Functional similarity between HPV16E7, SV40 large T and adenovirus E1a proteins. Oncogene 4:153-158.
53. Walker, T. A., B. A. Wilson, J. A. M. Lewis, and J. L. Cook. 1991. E1A oncogene induction of cytolytic susceptibility eliminates sarcoma cell tumorigenicity. Proc. Natl. Acad. Sci. USA 88:6491-6495.
54. Wang, H.-G. H., Y. Rikitake, M. C. Carter, P. Yaciuk, S. E. Abraham, B. Zerler, and E. Moran. 1993. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67:476-488.
55. Yang, X.-J., V. V. Ogryzko, J. Nishikawa, B. Howard, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with the adenoviral protein E1A. Nature 382:319-324.
56. Yee, C., I. Krishnan-Hewlett, C. Baker, R. Schlegel, and P. Howley. 1985. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119:361-366.
57. Yuan, Z. M., Y. Huang, T. Ishiko, S. Nakada, T. Utsugisawa, H. Shioya, Y. Utsugisawa, Y. Shi, R. Weichselbaum, and D. Kufe. 1999. Function for p300 and not CBP in the apoptotic response to DNA damage. Oncogene 18:5714-5717.
58. Zucker, M. L., and S. J. Flint. 1985. Infection and transformation of mouse cells by human adenovirus type 2. Virology 147:126-141.